10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 256 filers reported holding 10X GENOMICS INC in Q2 2024. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,028 | -97.7% | 138 | -98.2% | 0.00% | -100.0% |
| Q3 2022 | $215,000 | -37.9% | 7,539 | +2.2% | 0.01% | -58.1% |
| Q2 2022 | $346,000 | -35.8% | 7,378 | +4.2% | 0.03% | +3.3% |
| Q1 2022 | $539,000 | +28.9% | 7,081 | +152.4% | 0.03% | -14.3% |
| Q4 2021 | $418,000 | -29.0% | 2,806 | -13.7% | 0.04% | -25.5% |
| Q1 2021 | $589,000 | +99.7% | 3,253 | +55.9% | 0.05% | +74.1% |
| Q4 2020 | $295,000 | – | 2,086 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |